SUMER JACQUELYN L 4
4 · Cullinan Therapeutics, Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
SUMER JACQUELYN L
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-12-18$9.67/sh−3,480$33,652→ 135,432 total
Footnotes (2)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
- [F2]Includes 2,017 shares of common stock that the Reporting Person purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan for the purchase period of January 1, 2025 through June 30, 2025 that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).